Ftse Mib
32.642,30
-2,88%
DAX
18.046,90
-1,19%
S&P 500
5.416,00
-0,33%
NASDAQ
17.656,06
-0,07%
Bitcoin
66.969,22
0,32%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ SurModics Inc (SRDX) SurModics Inc (SRDX) Notizie

SurModics Inc

SRDX
42,00
0,00 (0,00%)
Ultimo aggiornamento: 15:45:31
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/6/202422:57EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/6/202413:00BWSurmodics Awarded Thrombectomy Products Agreement with..
30/5/202400:36PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
29/5/202414:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/5/202413:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/5/202413:27EDGAR2Form 8-K - Current report
29/5/202413:00BWSurmodics Enters into Definitive Agreement to be Acquired by..
24/5/202422:01EDGAR2Form SD - Specialized disclosure report
01/5/202413:00BWSurmodics Reports Second Quarter of Fiscal Year 2024..
19/4/202413:00BWSurmodics to Report Second Quarter of Fiscal 2024 Financial..
27/2/202414:00BWSurmodics to Participate in Upcoming Investor Conferences in..
12/2/202422:22EDGAR2Form 8-K - Current report
12/2/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202417:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202414:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202413:00EDGAR2Form 8-K - Current report
01/2/202413:00BWSurmodics Reports First Quarter of Fiscal Year 2024..
29/1/202422:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202413:30BWSurmodics Announces Successful Early Clinical Use of Pounce™..
16/1/202413:30BWSurmodics to Host Virtual Annual Meeting of Shareholders
03/1/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:05EDGAR2Form DEF 14A - Other definitive proxy statements
18/12/202322:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/12/202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202316:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
17/11/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202313:30BWSurmodics Announces TRANSCEND Trial 36-Month Data Presented..
14/11/202322:05BWSurmodics to Participate in the Piper Sandler Healthcare..
08/11/202313:30BWSurmodics Reports Fourth Quarter and Fiscal Year 2023..
Apertura: 41,95 Min: 41,90 Max: 42,00
Chiusura: 42,00

La tua Cronologia

NASDAQ
SRDX
SurModics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network